FULCRUM THERAPEUTICS, INC. Shares Outstanding (Cover Page)
FULCRUM THERAPEUTICS, INC. (FULC) had Shares Outstanding (Cover Page) of 76.30 million shares as of 2026-07-23, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-23: Entity Common Stock, Shares Outstanding 76.30M shares.
- 2026-04-20: Entity Common Stock, Shares Outstanding 66.63M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 66.60M shares.
- 2025-10-22: Entity Common Stock, Shares Outstanding 54.12M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-23 | 76.30M shares 10-Q · filed 2026-07-30 |
| 2026-04-20 | 66.63M shares 10-Q · filed 2026-04-27 |
| 2026-02-17 | 66.60M shares 10-K · filed 2026-02-24 |
| 2025-10-22 | 54.12M shares 10-Q · filed 2025-10-29 |
| 2025-07-22 | 54.09M shares 10-Q · filed 2025-07-29 |
| 2025-04-24 | 53.98M shares 10-Q · filed 2025-05-01 |
| 2025-02-18 | 53.98M shares 10-K · filed 2025-02-25 |
| 2024-11-06 | 53.94M shares 10-Q · filed 2024-11-13 |
| 2024-07-24 | 62.40M shares 10-Q · filed 2024-07-31 |
| 2024-05-06 | 62.15M shares 10-Q · filed 2024-05-13 |
| 2024-02-20 | 61.94M shares 10-K · filed 2024-02-27 |
| 2023-10-31 | 61.82M shares 10-Q · filed 2023-11-07 |
| 2023-07-27 | 61.82M shares 10-Q · filed 2023-08-03 |
| 2023-05-08 | 61.76M shares 10-Q · filed 2023-05-15 |
| 2023-03-02 | 61.76M shares 10-K/A · filed 2023-06-26 |
| 2022-11-01 | 52.05M shares 10-Q · filed 2022-11-08 |
| 2022-08-04 | 41.01M shares 10-Q · filed 2022-08-11 |
| 2022-05-02 | 40.85M shares 10-Q · filed 2022-05-09 |
| 2022-02-24 | 40.64M shares 10-K/A · filed 2023-06-26 |
| 2021-10-28 | 40.55M shares 10-Q · filed 2021-11-04 |
| 2021-08-03 | 32.71M shares 10-Q · filed 2021-08-10 |
| 2021-04-29 | 32.68M shares 10-Q · filed 2021-05-06 |
| 2021-02-25 | 32.67M shares 10-K/A · filed 2023-06-23 |
| 2020-11-04 | 27.46M shares 10-Q · filed 2020-11-10 |
| 2020-08-04 | 27.45M shares 10-Q · filed 2020-08-11 |
| 2020-05-08 | 23.37M shares 10-Q · filed 2020-05-13 |
| 2020-02-28 | 23.36M shares 10-K · filed 2020-03-05 |
| 2019-11-08 | 23.34M shares 10-Q · filed 2019-11-14 |
| 2019-08-23 | 23.34M shares 10-Q · filed 2019-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |